GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Valuation Rank

Marinomed Biotech AG (STU:93Z) Valuation Rank


View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Marinomed Biotech AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG (STU:93Z) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Valuation Rank
Comparable Companies
XKRX:088910 XKRX:208140 XKRX:005860 XKRX:009780 XKRX:005990 XKRX:006090 XKRX:025880 XKRX:066360 XKRX:003310 XKRX:005670 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MARI:Austria
Address
Hovengasse 25, Korneuburg, AUT, 2100
Website
https://www.marinomed.com
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.